Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M33.3Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-0.1
Enterprise Value $M-32.9EPS (TTM) $-1.8Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book0.610-y EBITDA Growth Rate %--Quick Ratio12.8Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio12.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-37.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-39.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NVLS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVLSJulian Robertson 2015-09-30 Buy 1.13%$12.74 - $20.16
($16.43)
$ 2.14-87%New holding650,915
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVLS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVLS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Carruthers R MichaelExec Vice President / CFO 2016-12-02Buy24,000$2.092.39view
Rodman David MalcomExec Vice President and CMO 2016-10-04Sell5,820$7.96-73.12view
Rodman David MalcomExec Vice President and CMO 2016-07-05Sell5,950$4.66-54.08view
Congleton JonPresident and CEO 2016-06-16Buy5,000$3.87-44.7view
Congleton JonPresident and CEO 2016-03-24Buy5,000$4.22-49.29view
Congleton JonPresident and CEO 2016-03-22Buy5,000$4.38-51.14view
Congleton JonPresident and CEO 2015-12-11Buy5,000$8.1-73.58view
CONWAY ROBERT EDirector 2015-12-09Buy10,000$8.1-73.58view
Flynn James E 2015-06-23Buy250,000$14-84.71view
Hawkes Bay Master Investors (C10% Owner 2015-06-22Buy17,200$14.69-85.43view

Quarterly/Annual Reports about NVLS:

News about NVLS:

Articles On GuruFocus.com

More From Other Websites
Should You Buy Nivalis Therapeutics Inc (NVLS)? Dec 07 2016
6 Companies That Destroyed Shareholders Last Week Dec 03 2016
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda Dec 02 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nivalis... Nov 29 2016
Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD) Nov 29 2016
Fitbit, Vodafone Sink into Tuesday’s 52-Week Low Club Nov 29 2016
Nivalis Therapeutics Crumbles on Failed Mid-Stage Trial Nov 29 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving... Nov 29 2016
Nivalis Cystic Fibrosis Fails Phase 2 Study (NVLS) Nov 29 2016
Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint Nov 29 2016
Nivalis' stock loses half its value after failed trial prompts analyst downgrades Nov 29 2016
Nivalis Therapeutics downgraded by Stifel, Raymond James and Robert W. Baird Nov 29 2016
Nivalis Therapeutics plummet as cystic fibrosis drug study fails Nov 28 2016
NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 28 2016
Nivalis Therapeutics Announces Results from Phase 2 Clinical Trial of Cavosonstat for Treatment of... Nov 28 2016
NIVALIS THERAPEUTICS, INC. Financials Nov 16 2016
NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 14 2016
Nivalis Therapeutics Announces Completion of Enrollment in Second Phase 2 Study of Cavosonstat for... Nov 14 2016
Nivalis Therapeutics Announces Completion of Enrollment in Second Phase 2 Study of Cavosonstat for... Nov 14 2016
Nivalis Therapeutics reports 3Q loss Nov 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)